Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

j_mendlein

Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy

January 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Moderna Therapeutics, mrna

Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein …
Appointment
nice_new_london_office_internal_3_web

NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy

January 4, 2018 Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma

NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …
News
pfizer_chrome_plate

Pfizer makes $830m drug discovery pact with Arvinas

January 4, 2018 Research and Development, Sales and Marketing Arvinas, Pfizer, biotech, drugs, pharma, pharmaceutical

Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing …
News
artificial-intelligence-2228610_640

New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018 Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …
News
allergan-westport-ireland_web

Allergan to axe over 1,000 positions in cost cutting measures

January 4, 2018 Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan was never far away from the headlines in 2017, particularly when it came to its second highest selling product, …
News
eye-1173863_960_720

Spark’s bright idea on $850,000 blindness gene therapy

January 3, 2018 Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical

Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …
News
Novartis image

Novartis’ Kisqali gains breakthrough status in premenopausal breast cancer

January 3, 2018 Research and Development, Sales and Marketing Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough …
News
mallinckrodt

Mallinckrodt bolsters business with $1.2bn buyout

January 3, 2018 Research and Development, Sales and Marketing Mallinckrodt, drugs, pharma, pharmaceutical, sucampo

Mallinckrodt has endured a tough 2017, with its share price falling by half over the course of the year. This …
News
epidiolex-100mg-carton-bottle-unenhanced-0074c-j10

GW Pharma applies to both EU and US for lead product

January 2, 2018 Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …
News
Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018 Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …
News
dermapace-product

FDA approves shock wave wound healing device

January 2, 2018 Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …
News
mylan_building

Mylan and Biocon biosimilar approval expands to Brazil

January 2, 2018 Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …
News
valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018 Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …
News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
News
2018

Seven pharma trends for 2018

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025